X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (79) 79
index medicus (78) 78
hematology (75) 75
female (65) 65
adult (63) 63
male (61) 61
middle aged (60) 60
transplantation (59) 59
aged (44) 44
oncology (42) 42
stem cells (40) 40
leukemia (33) 33
adolescent (31) 31
treatment outcome (30) 30
hematopoietic stem cells (29) 29
transplantation, homologous (29) 29
cancer (27) 27
survival (27) 27
recurrence (26) 26
young adult (26) 26
chemotherapy (25) 25
stem cell transplantation (23) 23
disease-free survival (22) 22
hematopoietic stem cell transplantation (22) 22
immunology (20) 20
retrospective studies (20) 20
bone-marrow-transplantation (19) 19
patients (18) 18
analysis (17) 17
care and treatment (17) 17
hematopoietic stem cell transplantation - methods (17) 17
stem-cell transplantation (17) 17
acute myeloid leukemia (16) 16
bone marrow (16) 16
leukemia, myeloid, acute - mortality (16) 16
remission induction (16) 16
research (16) 16
risk factors (16) 16
survival rate (16) 16
adults (15) 15
leukemia, myeloid, acute - therapy (15) 15
relapse (15) 15
transplantation conditioning - methods (15) 15
abridged index medicus (14) 14
hematology, oncology and palliative medicine (14) 14
remission (14) 14
therapy (13) 13
aml (12) 12
hematopoietic stem cell transplantation - adverse effects (12) 12
versus-host-disease (12) 12
acute lymphoblastic leukemia (11) 11
aged, 80 and over (11) 11
antineoplastic agents - therapeutic use (11) 11
diagnosis (11) 11
mice (11) 11
survival analysis (11) 11
acute lymphocytic leukemia (10) 10
acute myeloid-leukemia (10) 10
adult patients (10) 10
animals (10) 10
blood (10) 10
kaplan-meier estimate (10) 10
medical prognosis (10) 10
usage (10) 10
acute lymphatic leukemia (9) 9
acute lymphoblastic-leukemia (9) 9
acute lymphocytic-leukemia (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
combined modality therapy (9) 9
health aspects (9) 9
hemopoiesis (9) 9
lymphatic leukemia (9) 9
minimal residual disease (9) 9
prognosis (9) 9
prospective studies (9) 9
allogeneic transplantation (8) 8
clinical trials (8) 8
diseases (8) 8
graft-versus-host reaction (8) 8
inotuzumab ozogamicin (8) 8
leukemia, myeloid, acute - drug therapy (8) 8
leukemia, myeloid, acute - genetics (8) 8
mortality (8) 8
myelodysplastic syndrome (8) 8
myeloid leukemia (8) 8
outcomes (8) 8
transplants & implants (8) 8
unrelated donors (8) 8
1st complete remission (7) 7
age factors (7) 7
blinatumomab (7) 7
leukemia, myeloid, acute - pathology (7) 7
lymphocytes (7) 7
medicine & public health (7) 7
multivariate analysis (7) 7
mutation (7) 7
myelodysplastic syndromes (7) 7
myelodysplastic syndromes - therapy (7) 7
neoplasms. tumors. oncology. including cancer and carcinogens (7) 7
phase-ii (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 9, pp. 855 - 864
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 8, pp. 740 - 753
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2493 - 2498
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1035 - 1044
Journal Article
Blood, ISSN 0006-4971, 07/2018, Volume 132, Issue 3, pp. 245 - 253
Mature T-and natural killer (NK)-cell neoplasms comprise a group of morphologically, immunophenotypically, molecularly, and clinically heterogeneous disorders... 
BRENTUXIMAB VEDOTIN | NON-HODGKIN-LYMPHOMA | PHASE-II | MYCOSIS-FUNGOIDES | LONG-TERM REMISSIONS | MARROW-TRANSPLANTATION | SEZARY-SYNDROME | RETROSPECTIVE ANALYSIS | HEMATOLOGY | PREVIOUSLY UNTREATED PATIENTS | WORKING PARTY
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2012, Volume 120, Issue 26, pp. 5185 - 5187
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2018, Volume 19, Issue 12, pp. 1668 - 1679
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 09/2018, Volume 30, Issue 5, pp. 301 - 307
PURPOSE OF REVIEWT – and natural killer (NK) cell neoplasms are a heterogeneous group of rare diseases with often inferior outcome. Only few studies exist,... 
LEUKEMIA-LYMPHOMA | MYCOSIS-FUNGOIDES | PHASE-II | natural killer cell lymphoma | WORKING PARTY | SOCIETY | ONCOLOGY | HIGH-DOSE THERAPY | LEUKEMIA/LYMPHOMA | allogeneic transplantation | LONG-TERM REMISSIONS | MARROW-TRANSPLANTATION | T-cell lymphoma | BLOOD | Care and treatment | Transplantation | T cell lymphoma | Methods | Stem cells
Journal Article
Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 26, pp. 6226 - 6233
Journal Article
Journal Article